These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

622 related items for PubMed ID: 29301539

  • 1. Development of an inventory of goals using the International Classification of Functioning, Disability and Health in a population of non-ambulatory children and adolescents with cerebral palsy treated with botulinum toxin A.
    Nguyen L, Mesterman R, Gorter JW.
    BMC Pediatr; 2018 Jan 04; 18(1):1. PubMed ID: 29301539
    [Abstract] [Full Text] [Related]

  • 2. Development of a framework to define the functional goals and outcomes of botulinum toxin A spasticity treatment relevant to the child and family living with cerebral palsy using the International Classification of Functioning, Disability and Health for Children and Youth.
    Preston N, Clarke M, Bhakta B.
    J Rehabil Med; 2011 Nov 04; 43(11):1010-5. PubMed ID: 22031347
    [Abstract] [Full Text] [Related]

  • 3. Effects of Botulinum Toxin Treatment in Nonambulatory Children and Adolescents With Cerebral Palsy: Understanding Parents' Perspectives.
    Nguyen L, Di Rezze B, Mesterman R, Rosenbaum P, Gorter JW.
    J Child Neurol; 2018 Oct 04; 33(11):724-733. PubMed ID: 30039731
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Botulinum toxin type A in children and adolescents with severe cerebral palsy: a retrospective chart review.
    Mesterman R, Gorter JW, Harvey A, Lockhart J, McEwen-Hill J, Margallo K, Goldie N.
    J Child Neurol; 2014 Feb 04; 29(2):210-3. PubMed ID: 23965398
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of botulinum toxin A in children with cerebral palsy in Gross Motor Function Classification System levels IV and V: a systematic review.
    Pin TW, Elmasry J, Lewis J.
    Dev Med Child Neurol; 2013 Apr 04; 55(4):304-13. PubMed ID: 23095013
    [Abstract] [Full Text] [Related]

  • 7. Combining strength training and botulinum neurotoxin intervention in children with cerebral palsy: the impact on muscle morphology and strength.
    Williams SA, Elliott C, Valentine J, Gubbay A, Shipman P, Reid S.
    Disabil Rehabil; 2013 Apr 04; 35(7):596-605. PubMed ID: 22928803
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Longitudinal assessment of gait quality in children with bilateral cerebral palsy following repeated lower limb intramuscular Botulinum toxin-A injections.
    Read FA, Boyd RN, Barber LA.
    Res Dev Disabil; 2017 Sep 04; 68():35-41. PubMed ID: 28735160
    [Abstract] [Full Text] [Related]

  • 10. Quantitative evaluation for spasticity of calf muscle after botulinum toxin injection in patients with cerebral palsy: a pilot study.
    Lin YC, Lin IL, Chou TF, Lee HM.
    J Neuroeng Rehabil; 2016 Mar 12; 13():25. PubMed ID: 26969526
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Intramuscular botulinum toxin prior to comprehensive rehabilitation has no added value for improving motor impairments, gait kinematics and goal attainment in walking children with spastic cerebral palsy.
    Schasfoort F, Pangalila R, Sneekes EM, Catsman C, Becher J, Horemans H, Stam HJ, Dallmeijer AJ, Bussmann JBJ.
    J Rehabil Med; 2018 Aug 22; 50(8):732-742. PubMed ID: 30080235
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral palsy (UPDATE).
    Hoare BJ, Wallen MA, Imms C, Villanueva E, Rawicki HB, Carey L.
    Cochrane Database Syst Rev; 2010 Jan 20; 2010(1):CD003469. PubMed ID: 20091546
    [Abstract] [Full Text] [Related]

  • 17. Modified constraint-induced movement therapy or bimanual occupational therapy following injection of Botulinum toxin-A to improve bimanual performance in young children with hemiplegic cerebral palsy: a randomised controlled trial methods paper.
    Hoare BJ, Imms C, Rawicki HB, Carey L.
    BMC Neurol; 2010 Jul 05; 10():58. PubMed ID: 20602795
    [Abstract] [Full Text] [Related]

  • 18. Perspectives on rehabilitation of children with cerebral palsy: exploring a cross-cultural view of parents from India and Canada using the international classification of functioning, disability and health.
    Jindal P, MacDermid JC, Rosenbaum P, DiRezze B, Narayan A.
    Disabil Rehabil; 2018 Nov 05; 40(23):2745-2755. PubMed ID: 28747138
    [Abstract] [Full Text] [Related]

  • 19. Functional outcomes of multilevel botulinum toxin and comprehensive rehabilitation in cerebral palsy.
    Balbaloglu O, Basaran A, Ayoglu H.
    J Child Neurol; 2011 Apr 05; 26(4):482-7. PubMed ID: 21270468
    [Abstract] [Full Text] [Related]

  • 20. Should botulinum toxin A injections be repeated in children with cerebral palsy? A systematic review.
    Kahraman A, Seyhan K, Değer Ü, Kutlutürk S, Mutlu A.
    Dev Med Child Neurol; 2016 Sep 05; 58(9):910-7. PubMed ID: 27103334
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.